Company Filing History:
Years Active: 2004-2007
Title: Scott Furlan: Innovator in Cell Lysis Detection
Introduction
Scott Furlan is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of cell biology through his innovative methods of detecting specific cell lysis. With a total of 2 patents, Furlan's work has implications in various applications, particularly in medical and biological research.
Latest Patents
Furlan's latest patents focus on methods of detecting specific lysis of a cell by a lytic agent. The invention provides a process that involves contacting a labeled target cell with a lytic agent and detecting fluorescence in the target cell. The target cells are labeled with two fluorescent labels: one that labels the plasma membrane and another that labels the cytosol. The release of the cytosolic label from the target cell indicates that the target cell has been lysed. Additionally, the invention includes methods for detecting the presence of a cell that specifically lyses a target cell, as well as methods for detecting antibodies that specifically lyse target cells. These methods are useful in a variety of applications.
Career Highlights
Scott Furlan is currently associated with the J. David Gladstone Institutes, where he continues to advance his research and innovations. His work has garnered attention for its potential impact on understanding cell behavior and developing therapeutic strategies.
Collaborations
Furlan collaborates with esteemed colleagues, including Douglas F. Nixon and Adrian B. McDermott. Their combined expertise enhances the research efforts at the Gladstone Institutes.
Conclusion
Scott Furlan's contributions to the field of cell lysis detection exemplify the importance of innovation in scientific research. His patents and ongoing work continue to pave the way for advancements in cell biology and therapeutic applications.